DAMAGING CARDIAC GENE VARIANTS DETERMINE RESPONSE TO LVAD THERAPY
Eric Rome(University of Nebraska Medical Center), Brian D. Lowes(University of Nebraska Medical Center), Michael J. Moulton(Nebraska Medical Center), Junhan Zhao(Harvard University), Daniel R. Anderson(University of Nebraska Medical Center), Eugenia Raichlin(University of Nebraska Medical Center), Jeff Kittrell(University of Nebraska Medical Center), John Um(University of Nebraska Medical Center), Alexandra M. Moulton(University of Nebraska Medical Center), Ronald Redder(University of Nebraska Medical Center), Kajari Dhar(University of Nebraska Medical Center), James D. Eudy(University of Nebraska Medical Center), Geoffrey Thiele(University of Nebraska Medical Center)
Cited by 0
Related Papers
Production of stem cells with embryonic characteristics from human umbilical cord blood
|Cell Proliferation|2005|214
Genomic Structure and Identification of Novel Mutations in Usherin, the Gene Responsible for Usher Syndrome Type IIa
|The American Journal of Human Genetics|2000|180
DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension
|Science Advances|2020|80
Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension
|European Respiratory Journal|2020|69